Endoscopic Mucosal Resection in the Esophagus with a New Rigid Device: an Animal Study

Background and Study Aims: There is a growing trend toward the use of minimally invasive endoscopic methods to treat early esophageal cancers. Although there is continuing controversy regarding the management of Barrett’s esophagus and the value of surveillance programs continues to be debated, the ultimate goal is to eradicate all of the foci of intestinal metaplasia and hence the risk of developing an adenocarcinoma. A number of ablative techniques have so far been applied, but none has yet been shown to be superior and entirely satisfactory. The present study evaluates the feasibility, efficacy, and safety of a promising new method of endoscopic mucosal resection (EMR) in a sheep model, based on the use of a modified rigid esophagoscope.
Materials and Methods: The resectoscope consists of a rigid esophagoscope with a distal transparent window through which the mucosa and part of the submucosa are sucked in and then resected with a wire loop. The sheep model was chosen because of its similarities to human anatomy with regard to the thickness and histological structure of the esophagus. Fifty-five separate hemicircumferential resections and 11 circumferential resections were carried out in 21 and 11 animals, respectively. Mitomycin C, an agent inhibiting fibroblast proliferation, was administered at different time intervals after eight circumferential resections to prevent the development of esophageal strictures.
Results : All of the specimens of hemicircumferential resections were obtained as single distinct pieces and were easily examined histologically. The surface of the specimen correlated with the size of the window and ranged from 6 to 12 cm². In circumferential resections, the specimens were obtained in two pieces. An accurate resection depth through the submucosa was achieved in 58 of 65 resected specimens. No complications occurred after hemicircumferential resections. Complications after circumferential resections (stenosis or perforation, or both) were minimized after appropriate timing of mitomycin C administration.
Conclusions: This EMR method offers a promising approach in comparison with other options currently available. It appears to be superior in terms of the size of the resected specimen, the precision and regularity of the resection depth, and the accuracy of histological diagnosis with safety margins. Hemicircumferential EMRs have been shown to be safe in the sheep model. This new technique warrants further animal studies before being used for circumferential EMR in humans.

References

• 1 Kato H. Diagnosis and treatment of esophageal neoplasms.  Jpn J Cancer Res. 1997;  86 993-1009
• 2 Roth J A, Putman J B. Surgery for cancer of the esophagus.  Semin Oncol. 1994;  4 453-461
• 3 Earlam R, Cunha-Melo J R. Esophageal squamous cell carcinoma: a critical review of radiotherapy.  Br J Surg. 1980;  67 457-461
• 4 Collard J M, Otte J B, Reynaert M. et al . Quality of life three years or more after esophagectomy for cancer.  J Thorac Cardiovasc Surg. 1992;  104 391-394
• 5 Overholt B F. Laser and photodynamic therapy of esophageal cancer.  Semin Surg Oncol. 1992;  8 191-203
• 6 Gossner L, May A, Stolte M. et al . KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett’s esophagus.  Gastrointest Endosc. 1999;  49 8-12
• 7 Sampliner R E, Hixson L J, Fennerty M B. et al . Regression of Barrett’s esophagus by laser ablation in an anacid environment.  Dig Dis Sci. 1993;  38 365-368
• 8 Schultz H, Miehlke S, Antos D. et al . Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.  Gastrointest Endosc. 2000;  51 659-663
• 9 Van Laethem J L, Cremer M, Peny M O. et al . Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.  Gut. 1998;  43 747-751
• 10 Sharma P, Bhattacharyya A, Garewal H S. et al . Durability of new squamous epithelium after endoscopic reversal of Barrett’s esophagus.  Gastrointest Endosc. 1999;  50 159-164
• 11 Savary J F, Grosjean P, Monnier P. et al . Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases.  Endoscopy. 1998;  30 258-265
• 12 Overholt B F, Panjehpour M, Haydek J M. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients.  Gastrointest Endosc. 1999;  49 1-7
• 13 Inoue H, Takeshita K, Hori H. et al . Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions.  Gastrointest Endosc. 1993;  39 58-62
• 14 Nijhawan P K, Wang K K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus.  Gastrointest Endosc. 2000;  52 328-332
• 15 Ell C, May A, Gossner L. et al . Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus.  Gastroenterology. 2000;  118 670-677
• 16 Grosjean P. La mucosectomie endoscopique oesophagienne: étude pré-clinique.  Probl Actuelles Otorhinolaryngol. 1998;  21 293-302
• 17 Liu J B, Miller L S, Goldberg B B. et al . Transnasal US of the esophagus: preliminary morphologic and function studies.  Radiology. 1992;  184 721-727
• 18 Bays R, Wagnieres G, Robert D. et al . Light dosimetry for photodynamic therapy in the esophagus.  Lasers Surg Med. 1997;  20 290-303
• 19 Taniguchi D K, Martin R W, Trowers E A. et al . Changes in esophageal wall layers during motility: measurements with a new miniature ultrasound suction device.  Gastrointest Endosc. 1993;  39 146-152
• 20 Khaw P T, Doyle J W, Sherwood M B. et al . Prolonged localized tissue effects from 5-minute exposure to fluorouracil and mitomycin C.  Arch Ophthalmol. 1993;  111 263-267
• 21 Rabhar R, Jones D T, Nuss R C. et al . The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract.  Arch Otolaryngol Head Neck Surg. 2002;  128 401-406
• 22 Eliachar R, Eliachar I, Esclamado R. et al . Can topical mitomycin prevent laryngotracheal stenosis?.  Laryngoscope. 1999;  109 1594-1600
• 23 May A, Gossner L, Pech O. et al . Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus: curative treatment using local endoscopic treatment techniques.  Endoscopy. 2002;  34 604-610
• 24 Kida M. Endoscopic tumor diagnosis and treatment.  Endoscopy. 2000;  32 836-844
• 25 Kahaleh M, van Laethem J L, Nagy N. et al . Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression.  Endoscopy. 2002;  34 950-955
• 26 Basu K K, Pick B, Bale R. et al . Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium.  Gut. 2002;  51 776-780
• 27 Ackroyd R, Brown N J, Stephenson T J. et al . Ablation treatment for Barrett’s oesophagus: what depth of tissue destruction is needed.  J Clin Pathol. 1999;  52 509-512
• 28 Conio M, Sorbi D, Batts K P. et al . Endoscopic circumferential esophageal mucosectomy in a porcine model: an assessment of technical feasibility, safety, and outcome.  Endoscopy. 2001;  33 791-794